英伟达、艾伯维公司、福泰制药和一家石油巨头:CNBC的“最终交易”

原标题:英伟达、艾伯维公司、福泰制药和一家石油巨头:CNBC的“最终交易”

tube x日本,one.yg99.aqq-SCRiS8JmdYRnV-英伟达、艾伯维公司、福泰制药和一家石油巨头:CNBC的“最终交易”。

On CNBC's "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named NVIDIA Corporation (NASDAQ:NVDA) as her final trade.

NVIDIA recently announced a 10-for-1 stock split. The semiconductor giant revealed this decision during its recent quarterly earnings report. The split-adjusted trading commenced on Monday, June 10.

Jim Lebenthal of Cerity Partners picked Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), which is a biopharmaceutical company.

On Friday, Vertex revealed positive long-term data on CASGEVY (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress.

Don't forget to check out our premarket coverage here

Kevin Simpson of Capital Wealth Planning named ConocoPhillips (NY SE:COP), saying the acquisition of Marathon Oil Corporation (NYSE:MRO) will be aggregate over tim

On Friday, BofA Securities analyst Kalei Akamine reinstated ConocoPhillips with a Buy rating and announced a price target of $147.

Rob Sechan of NewEdge Wealth said AbbVie Inc. (NYSE:ABBV) has an attractive valuation, wonderful pipeline and a great yield.

On June 6, AbbVie released topline results from the Phase 2 PICCOLO trial evaluating investigational mirvetuximab soravtansine (Elahere) monotherapy in heavily pre-treated patients with folate receptor-alpha (FRα) positive, platinum-sensitive ovarian cancer (PSOC). The study met its primary endpoint with an objective response rate (ORR) of 51.9%.

Price Action:

Image generated using artificial intelligence via Midjourney.

  这是张永保持乐观的理由,而2023年,已有多年积累的他为自己定下了更高的招商目标,“总要给自己增加点压力”。目前,他已经约好了开工后要上门拜访的企业,“时间初步定在了大年初十”。.xhtml返回搜狐,查看更多

责任编辑:

声明:该文观点仅代表作者本人,搜狐号系信息发布平台,搜狐仅提供信息存储空间服务。
发布于:伊春南岔区
阅读 ()
推荐阅读
免费获取
今日搜狐热点
今日推荐